Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-17T07:24:38.575Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic-induced dystonia: incidence and risk factors

Published online by Cambridge University Press:  16 April 2020

Massimo Ballerini ,
Simona Bellini ,
Carlo Niccolai ,
Valentina Pieroni  and
Maurizio Ferrara
Massimo Ballerini
Affiliation:
Department of Mental Health, University of Florence, Florence, Italy
Simona Bellini*
Affiliation:
Psychiatric Unit, Department of Neurologic and Psychiatric Sciences, University of Florence, Policlinico di Careggi. Via G.di Vittorio, 25, 50015Grassina Florence, Italy
Carlo Niccolai
Affiliation:
Mental Health Turin, Turin, Italy
Valentina Pieroni
Affiliation:
Psychiatric Unit, Department of Neurologic and Psychiatric Sciences, University of Florence, Policlinico di Careggi. Via G.di Vittorio, 25, 50015Grassina Florence, Italy
Maurizio Ferrara
Affiliation:
Psychiatric Unit, Department of Neurologic and Psychiatric Sciences, University of Florence, Policlinico di Careggi. Via G.di Vittorio, 25, 50015Grassina Florence, Italy
*
*E-mail address:[email protected] (S. Bellini).
Get access

Summary

Retrospective evaluation of patients admitted consecutively to the psychiatric units of two general hospitals in Florence, to evaluate the rate and risk factors of neuroleptic-induced dystonia (NDA). One hundred and fifty-nine patients out of 2354 reviewed charts were included. The incidence of NDA was 15.7%. Multivariate analyses revealed that both age and neuroleptization speed (NS)—a new variable—were related to the occurrence of dystonia.

Keywords

Extrapyramidal side effectsExtrapyramidal syndromeAcute neurodystoniaNeuroleptics
Type
Short communication
Information
European Psychiatry , Volume 17 , Issue 6 , October 2002 , pp. 366 - 368
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aguilar, EJMatcheri, SKMartìnez-Quiles, MDHernàndez, JGomez-Beneyto, MSchooler, NR. Predictors of acute dystonia in first-episode psychotic patients. Am J Psychiatry 1994;151:1819–21.Google ScholarPubMed
Ayd, FJ. A survey of drug induced extra pyramidal reactions. JAMA 1961;175:102–8.CrossRefGoogle Scholar
Casey, DE. Motor and mental aspects of acute extra pyramidal syndromes. Acta Psychiatr Scand 1994;89(S 380):14–20.CrossRefGoogle Scholar
Hyman, SE. Manuale delle Emergenze Psychiatriche; Graw-Hill, Mc ed., II Italian edition (1990) of II American edition (1988); 457.Google Scholar
Keepers, GAClappinson, VICasey, DE. Initial anti-cholinergic prophylaxis for neuroleptic induced extra pyramidal syndromes. Arch Gen Psychiatry 1983;40:1113–7.CrossRefGoogle Scholar
Khanna, RArunava, DDamodaran, SS. Prospective study of neuroleptic-induced dystonia in mania and schizophrenia. Am J Psychiatry 1992;149:511–3.Google Scholar
Kopala, LC. Spontaneous and drug-induced movement disorders in schizophrenia. Acta Psychiatr Scand 1996;94:12–7.CrossRefGoogle Scholar
Goldberg, D. Manuale del Maudsley Hospital di Psichiatria Pratica; Il Pensiero Scientifico Ed., I Italian editionof III English edition (1997); 266.Google Scholar
Remington, GJVoineskos, GPollock, BReed, KCoulter, K. Prevalence of neuroleptic-induced dystonia in mania and schizophrenia. Am J Psychiatry 1990;147:1231–3.Google Scholar
Sramek, JJ. Anti-cholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study. J Clin Psychiatry 1986;47:305–9.Google Scholar
Submit a response

Comments

No Comments have been published for this article.